Blood Transfusion Diagnostics Market Growth: Key Players and Market Strategies
Blood
Transfusion Diagnostics Market Size was estimated at USD 4.70 billion in
2022 and is poised to reach at 8.38 billion in 2030 anticipated to expand at a
compound annual growth rate approx. CAGR of 7.2% for the forecast period of
2023-2030.
The Transfusion Diagnostics Market is a rapidly growing
sector in the healthcare industry, driven by the increasing demand for safe and
reliable blood transfusions. This market encompasses a range of diagnostic
tests and technologies that are used to ensure compatibility between blood
donors and recipients, minimize the risk of transfusion-related complications,
and improve patient outcomes.
One of the key factors driving the growth of this market is
the rising number of blood transfusions performed worldwide. Blood transfusions
are essential in various medical procedures, including surgeries, trauma
management, cancer treatments, and organ transplants. As the prevalence of
these conditions continues to rise, so does the need for accurate and efficient
transfusion diagnostics.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2968
Another significant driver is the increasing awareness about
blood safety among healthcare providers and patients. With growing concerns
about infectious diseases such as HIV/AIDS, hepatitis B and C, Zika virus, and
emerging pathogens like COVID-19, there is a heightened focus on ensuring that
donated blood is thoroughly screened for potential infections.
KEY MARKET SEGMENTS
By Product
·
Consumables
·
Instruments
·
Services
By Technique
·
PCR-based and Microarray Techniques
·
Assay-based Techniques
·
Massively Parallel Sequencing Techniques
·
Other Techniques
By Test Type
·
Antibody Screening
·
HLA Typing
·
Cross-matching Tests
·
ABO Blood Tests
·
Antigen Typing
Major Players Listed in the Report are as Follows:
Grifols,
S.A.; Merck KGaA; Bio-Rad Laboratories, Inc.; Immucor, Inc.; Novacyt Group;
Danaher Corporation; Agena Bioscience, Inc.; Ortho Clinical Diagnostics; and
Quotient, Ltd., and others.
Other
Report
Hormone
Replacement Therapy Market Growth
About US:
SNS Insider has been a leader in data and analytics globally
with its authentic consumer and market insights. The trust of our clients and
business partners has always been at the center of who we are as a company. We
are a business that leads the industry in innovation, and to support the
success of our clients, our highly skilled engineers, consultants, and data
scientists have consistently pushed the limits of the industry with innovative
methodology and measuring technologies.
We assist our clients to anticipate industrial, economic,
and consumer trends to drive disruptive change by fusing global experience with
local information from experts throughout the world. We bring context to
strategic and tactical data by bridging approaches based on data science and
field research, assisting you in addressing your most pressing problems and
spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Comments
Post a Comment